INSIGHTS ON CLINICAL TRIAL PARTNERING

• Investigator Databank And DQS: Welcoming New Consortium Members

  Join the Data Query System consortium to access a comprehensive, collaborative platform that enhances clinical trial feasibility, site selection, and investigator engagement.

• The High Cost Of CRO Turnover (And How You Can Avoid It)

  Though some turnover is an inevitable part of a business’s life cycle, there are several strategies available to ensure a consistent CRO team throughout the span of your trial.

• Harnessing AI for Pre-Award Landscape Analysis And Site Selection

  AI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.

• Providing Clinical Trial Patients With Transportation

  Explore how thoughtful, well-supported transportation strategies can reduce barriers, enhance participant retention, and strengthen the overall success of clinical trials.

• The Silent Saboteurs: Why Rater Drift And Site Unpreparedness Cost CNS Trials More

  3/25/2026

  High-end technology cannot fix poor rater preparation or complex patient needs. True data integrity requires bridging the gap between digital platforms and the reality of clinical implementation.

• The Real Reason Sites Haven't Digitized

  5/11/2026

  Reducing site burden doesn’t always require major change. Streamlining a single workflow can improve efficiency, strengthen compliance, and give site staff more time to focus on patients and trial execution.

• 5 Myths About Patient Payments In Clinical Trials

  10/8/2025

  Digital payment solutions debunk myths around clinical trial compensation, improving participant retention, easing site burden, and enabling smoother global operations through faster, more reliable payments.

• Key Risk Areas that Can Derail Clinical Trials with Ocular Endpoints

  1/15/2025

  By embracing point-of-need models and strategic collaborations, sponsors and CROs can streamline ophthalmic trials and maximize ROI while advancing sight-saving therapies.

• Navigating The New Landscape Of Oncology Clinical Trials: A Strategic Imperative For Operations Teams

  6/18/2026

  The oncology landscape is growing but faces high screen-fail rates and trial complexity. To succeed, teams must move past traditional playbooks and adopt centralized pre-screening pipelines.